176 related articles for article (PubMed ID: 15193414)
1. Synthetic lipopeptide adjuvants and Toll-like receptor 2--structure-activity relationships.
Spohn R; Buwitt-Beckmann U; Brock R; Jung G; Ulmer AJ; Wiesmüller KH
Vaccine; 2004 Jun; 22(19):2494-9. PubMed ID: 15193414
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 6-independent signaling by diacylated lipopeptides.
Buwitt-Beckmann U; Heine H; Wiesmüller KH; Jung G; Brock R; Akira S; Ulmer AJ
Eur J Immunol; 2005 Jan; 35(1):282-9. PubMed ID: 15580661
[TBL] [Abstract][Full Text] [Related]
3. Immunostimulants and Toll-like receptor ligands obtained by screening combinatorial lipopeptide collections.
Reutter F; Jung G; Baier W; Treyer B; Bessler WG; Wiesmüller KH
J Pept Res; 2005 Mar; 65(3):375-83. PubMed ID: 15787968
[TBL] [Abstract][Full Text] [Related]
4. Recognition of lipopeptides by Toll-like receptors.
Takeda K; Takeuchi O; Akira S
J Endotoxin Res; 2002; 8(6):459-63. PubMed ID: 12697090
[TBL] [Abstract][Full Text] [Related]
5. Lipolanthionine peptides act as inhibitors of TLR2-mediated IL-8 secretion. Synthesis and structure-activity relationships.
Seyberth T; Voss S; Brock R; Wiesmüller KH; Jung G
J Med Chem; 2006 Mar; 49(5):1754-65. PubMed ID: 16509590
[TBL] [Abstract][Full Text] [Related]
6. Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1.
Manukyan M; Triantafilou K; Triantafilou M; Mackie A; Nilsen N; Espevik T; Wiesmüller KH; Ulmer AJ; Heine H
Eur J Immunol; 2005 Mar; 35(3):911-21. PubMed ID: 15714590
[TBL] [Abstract][Full Text] [Related]
7. Triacylated lipoproteins derived from Mycoplasma pneumoniae activate nuclear factor-kappaB through toll-like receptors 1 and 2.
Shimizu T; Kida Y; Kuwano K
Immunology; 2007 Aug; 121(4):473-83. PubMed ID: 17433078
[TBL] [Abstract][Full Text] [Related]
8. CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex.
Nakata T; Yasuda M; Fujita M; Kataoka H; Kiura K; Sano H; Shibata K
Cell Microbiol; 2006 Dec; 8(12):1899-909. PubMed ID: 16848791
[TBL] [Abstract][Full Text] [Related]
9. Lipopeptide epitopes extended by an Nepsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity.
Zhu X; Ramos TV; Gras-Masse H; Kaplan BE; BenMohamed L
Eur J Immunol; 2004 Nov; 34(11):3102-14. PubMed ID: 15368273
[TBL] [Abstract][Full Text] [Related]
10. Triacyl-lipopentapeptide adjuvants: TLR2-dependent activation of macrophages and modulation of receptor-mediated cell activation by altering acyl-moieties.
Müller SD; Müller MR; Huber M; Esche Uv Uv; Kirschning CJ; Wagner H; Bessler WG; Mittenbühler K
Int Immunopharmacol; 2004 Oct; 4(10-11):1287-300. PubMed ID: 15313427
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins.
Takeuchi O; Sato S; Horiuchi T; Hoshino K; Takeda K; Dong Z; Modlin RL; Akira S
J Immunol; 2002 Jul; 169(1):10-4. PubMed ID: 12077222
[TBL] [Abstract][Full Text] [Related]
12. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer.
Kang JY; Nan X; Jin MS; Youn SJ; Ryu YH; Mah S; Han SH; Lee H; Paik SG; Lee JO
Immunity; 2009 Dec; 31(6):873-84. PubMed ID: 19931471
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide.
Jin MS; Kim SE; Heo JY; Lee ME; Kim HM; Paik SG; Lee H; Lee JO
Cell; 2007 Sep; 130(6):1071-82. PubMed ID: 17889651
[TBL] [Abstract][Full Text] [Related]
14. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy.
Krutzik SR; Ochoa MT; Sieling PA; Uematsu S; Ng YW; Legaspi A; Liu PT; Cole ST; Godowski PJ; Maeda Y; Sarno EN; Norgard MV; Brennan PJ; Akira S; Rea TH; Modlin RL
Nat Med; 2003 May; 9(5):525-32. PubMed ID: 12692544
[TBL] [Abstract][Full Text] [Related]
15. Lipopeptide structure determines TLR2 dependent cell activation level.
Buwitt-Beckmann U; Heine H; Wiesmüller KH; Jung G; Brock R; Ulmer AJ
FEBS J; 2005 Dec; 272(24):6354-64. PubMed ID: 16336272
[TBL] [Abstract][Full Text] [Related]
16. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.
Köllisch G; Kalali BN; Voelcker V; Wallich R; Behrendt H; Ring J; Bauer S; Jakob T; Mempel M; Ollert M
Immunology; 2005 Apr; 114(4):531-41. PubMed ID: 15804290
[TBL] [Abstract][Full Text] [Related]
17. TLR2 looks at lipoproteins.
Schenk M; Belisle JT; Modlin RL
Immunity; 2009 Dec; 31(6):847-9. PubMed ID: 20064441
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of Toll-like receptors in chicken heterophils.
Kogut MH; Iqbal M; He H; Philbin V; Kaiser P; Smith A
Dev Comp Immunol; 2005; 29(9):791-807. PubMed ID: 15936435
[TBL] [Abstract][Full Text] [Related]
19. Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer.
Seya T; Akazawa T; Uehori J; Matsumoto M; Azuma I; Toyoshima K
Anticancer Res; 2003; 23(6a):4369-76. PubMed ID: 14666723
[TBL] [Abstract][Full Text] [Related]
20. A common human TLR1 polymorphism regulates the innate immune response to lipopeptides.
Hawn TR; Misch EA; Dunstan SJ; Thwaites GE; Lan NT; Quy HT; Chau TT; Rodrigues S; Nachman A; Janer M; Hien TT; Farrar JJ; Aderem A
Eur J Immunol; 2007 Aug; 37(8):2280-9. PubMed ID: 17595679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
